Log in

600557 Jiangsu Kanion Pharmaceutical Co. Ltd. SSE · China

Jiangsu Kanion Pharmaceutical Co. (600557) news

Jiangsu Kanion Pharmaceutical Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600557, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Jiangsu Kanion Pharmaceutical Co. news

We have not published a story on Jiangsu Kanion Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Jiangsu Kanion Pharmaceutical Co.

What is the ticker symbol of Jiangsu Kanion Pharmaceutical Co.?

Jiangsu Kanion Pharmaceutical Co. Ltd. trades under the ticker 600557 on SSE.

Where is Jiangsu Kanion Pharmaceutical Co. listed?

Jiangsu Kanion Pharmaceutical Co. Ltd. is listed on SSE.

Which country or territory is Jiangsu Kanion Pharmaceutical Co. listed under?

Our directory records Jiangsu Kanion Pharmaceutical Co. Ltd. under China.

What does Jiangsu Kanion Pharmaceutical Co. do?

Our directory classifies Jiangsu Kanion Pharmaceutical Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Jiangsu Kanion Pharmaceutical Co.?

The ISIN recorded for Jiangsu Kanion Pharmaceutical Co. Ltd. is CNE000001CL7.

Does aibio.space cover Jiangsu Kanion Pharmaceutical Co.?

aibio.space lists Jiangsu Kanion Pharmaceutical Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Jiangsu Kanion Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Jiangsu Kanion Pharmaceutical Co.: Shandong Boan Biotechnology Company., Limited., Livzon Pharmaceutical Group, Mabwell (Shanghai) Bioscience Co., Renhe Pharmacy Co., Shandong Sito Bio-technology Co., Shanxi C&Y Pharmaceutical Group Co..

Investor discussion: Jiangsu Kanion Pharmaceutical Co.

Members talk about Jiangsu Kanion Pharmaceutical Co. (600557). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600557 on TradingView.

Listing details

Jiangsu Kanion Pharmaceutical Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600557, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Jiangsu Kanion Pharmaceutical Co. Ltd.
Ticker
600557
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE000001CL7
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.